Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Blood Reviews|August 7, 2002
Control of von Willebrand factor multimer size and implications for diseaseJohn Pimanda, Philip HoggMethods in Molecular Biology (Clifton, N.J.)|May 10, 2019
Classification of Protein Disulphide BondsAster E Pijning, Philip HoggMethods in Molecular Biology (Clifton, N.J.)|May 10, 2019
Preparation of a Dithiol-Reactive Probe for PET Imaging of Cell DeathIvan Ho Shon, Michael P Gotsbacher, Jennifer Guille, et al.Oncotarget|February 28, 2018
Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine gliomaMaria Tsoli, Jie Liu, Laura Franshaw, et al.Cancer Chemotherapy and Pharmacology|January 26, 2021
A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumoursSunit Sarkar, Ben Tran, Lisa Horvath, et al.Journal of Autoimmunity|June 19, 2012
Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosisBill Giannakopoulos, Lu Gao, Miao Qi, et al.Leukemia|January 10, 2019
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesisJennifer R Lynch, Basit Salik, Patrick Connerty, et al.Blood Advances|December 12, 2022
Endoplasmic reticulum protein 5 attenuates platelet endoplasmic reticulum stress and secretion in a mouse modelAngelina J Lay, Alexander Dupuy, Lejla Hagimola, et al.Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.Research and Practice in Thrombosis and Haemostasis|July 23, 2021
Illustrated State-of-the-Art Capsules of the ISTH 2020 CongressSriram Krishnaswamy, Walter Ageno, Yaseen Arabi, et al.Pageof 1